Features

Breast Cancer Genes: When the Sequence Is Not Enough

It’s been nearly two decades since CCR researcher Thomas Waldmann, M.D., co-discovered interleukin-15 (IL-15), a cytokine and potent stimulator of antitumor memory CD8+ T cells. Now, in a major step towards the molecule’s clinical development, Waldmann—Chief of CCR’s Metabolism Branch—and his CCR colleagues have started the process of testing IL-15 in human cancer patients for the first time.
Read the full story about IL-15 »

News

Giving His All for ALL

Giving His All for ALL

A personal visit to Guatemala evolves into a sustained global outreach program in pediatric oncology.

Faculty Successes: 'NExT' Opportunities for CCR Investigators
in Drug Discovery and Development

Faculty Successes: “NExT” Opportunities for CCR Investigators in Drug Discovery and Development

The development of new therapeutics to prevent and treat cancer is one of the most important goals of CCR.

BRCA1 Variants Co-Conspire with MicroRNA-155

BRCA1 Variants Co-Conspire with MicroRNA-155

Recently discovered microRNAs (miRNAs) play an important biological role by switching “on” and “off” at different times during cell growth, death, development, and differentiation.

Fighting Fire with Fire, Immunologically

Fighting Fire with Fire, Immunologically

CCR scientists describe a new stem-cell-like memory T cell with potential to enhance and prolong immune responses against tumor cells.

An Early Career Off to a Stellar Start

An Early Career Off to a Stellar Start

James Gulley receives prestigious Presidential Award.


Improving an Immunotoxin

Improving an Immunotoxin

Immunotoxins are chimeric proteins that comprise a targeting domain (e.g., the Fv portion of a monoclonal antibody or ligand) and a toxin domain that is capable of causing cell death.

alt text

Recent CCR Awards:

View the new 2011 CCR awards.

 

alt text

Staff News at CCR

Staff announcements at CCR.

 


alt text

In Conversation: Clinical Fellow Jung-min Lee

CCR connections recently met up with clinical fellow Jung-min Lee, M.D.